Replies to post #462009 on Anavex Life Sciences Corp (AVXL)

[kevindenver]

I agree, the science of biomarkers and the need to include them in a trial seems to be increasing, if not be required for many indications.

I think I read here that for fragile X, there is a new biomarker.

[WilliamMunny]

You may be right, frrol, but I heard him as saying that they had been waiting on biomarker research - past tense - and now had their ducks in a row. He did reiterate on the PD trial that it still was scheduled for the second half of the year. We shall see.